Elevated lipoproteins and coronary artery calcium score combo independently Linked with ASCVD Risk
A recent study suggests that a combination of Lp(a) and CAC is also independently associated with ASCVD risk. The study findings were published in the Journal of the American College of Cardiology on February 21, 2022. Elevated lipoprotein(a) [Lp(a)] and coronary artery calcium (CAC) score are individually associated with increased atherosclerotic cardiovascular disease (ASCVD) risk.
While CAC has become a more-routine clinical test, the medical community has not yet embraced Lp(a) in the same way because the question of what to do about an elevated measure remains unanswered. Also, the relationship of Lp(a) to coronary artery calcium (CAC) scores are understudied. Therefore, Dr Anurag Mehta and his team conducted a study to investigate the independent and joint association of Lp(a) and CAC with ASCVD risk.
For more information check out the full story on the link below:
Elevated Lipoprotein(A) And CAC Score Combo Independently Linked With ASCVD Risk
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.